These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 8430199)
1. Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients. Haustein J; Laniado M; Niendorf HP; Louton T; Beck W; Planitzer J; Schöffel M; Reiser M; Kaiser W; Schörner W Radiology; 1993 Mar; 186(3):855-60. PubMed ID: 8430199 [TBL] [Abstract][Full Text] [Related]
2. MR diagnosis of head and neck tumors: comparison of contrast enhancement with triple-dose gadodiamide and standard-dose gadopentetate dimeglumine in the same patients. Vogl TJ; Mack MG; Juergens M; Stark M; Pegios W; Bergman C; Grevers G; Western A AJR Am J Roentgenol; 1994 Aug; 163(2):425-32. PubMed ID: 8037044 [TBL] [Abstract][Full Text] [Related]
3. MR evaluation of CNS tumors: dose comparison study with gadopentetate dimeglumine and gadoteridol. Yuh WT; Fisher DJ; Engelken JD; Greene GM; Sato Y; Ryals TJ; Crain MR; Ehrhardt JC Radiology; 1991 Aug; 180(2):485-91. PubMed ID: 2068317 [TBL] [Abstract][Full Text] [Related]
4. Gadodiamide injection and gadopentetate dimeglumine. A double-blind study in MR imaging of the CNS. Myhr G; Rinck PA; Børseth A Acta Radiol; 1992 Sep; 33(5):405-9. PubMed ID: 1389644 [TBL] [Abstract][Full Text] [Related]
5. Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine. Knopp MV; Bourne MW; Sardanelli F; Wasser MN; Bonomo L; Boetes C; Müller-Schimpfle M; Hall-Craggs MA; Hamm B; Orlacchio A; Bartolozzi C; Kessler M; Fischer U; Schneider G; Oudkerk M; Teh WL; Gehl HB; Salerio I; Pirovano G; La Noce A; Kirchin MA; Spinazzi A AJR Am J Roentgenol; 2003 Sep; 181(3):663-76. PubMed ID: 12933457 [TBL] [Abstract][Full Text] [Related]
6. MR arthrography of the shoulder with gadopentetate dimeglumine: influence of concentration, iodinated contrast material, and time on signal intensity. Kopka L; Funke M; Fischer U; Keating D; Oestmann J; Grabbe E AJR Am J Roentgenol; 1994 Sep; 163(3):621-3. PubMed ID: 8079856 [TBL] [Abstract][Full Text] [Related]
7. Clinical safety of gadopentetate dimeglumine. Nelson KL; Gifford LM; Lauber-Huber C; Gross CA; Lasser TA Radiology; 1995 Aug; 196(2):439-43. PubMed ID: 7617858 [TBL] [Abstract][Full Text] [Related]
8. Effect of the rate of gadopentetate dimeglumine administration on abdominal vascular and soft-tissue MR imaging enhancement patterns. Strouse PJ; Prince MR; Chenevert TL Radiology; 1996 Dec; 201(3):809-16. PubMed ID: 8939236 [TBL] [Abstract][Full Text] [Related]
9. MR imaging of pituitary region lesions with gadodiamide injection. Hald JK; Skalpe IO; Bakke SJ; Nakstad PH Acta Radiol; 1994 Jan; 35(1):65-9. PubMed ID: 8305277 [TBL] [Abstract][Full Text] [Related]
10. Safety assessment of gadopentetate dimeglumine in U.S. clinical trials. Goldstein HA; Kashanian FK; Blumetti RF; Holyoak WL; Hugo FP; Blumenfield DM Radiology; 1990 Jan; 174(1):17-23. PubMed ID: 2403679 [TBL] [Abstract][Full Text] [Related]
11. Lumbosacral spine: early and delayed MR imaging after administration of an expanded dose of gadopentetate dimeglumine in healthy, asymptomatic subjects. Jinkins JR; Rauch RA; Gee GT; Bazan C; Xiong L; Kashanian FK; Hanna EP Radiology; 1995 Oct; 197(1):247-51. PubMed ID: 7568831 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis of pancreatic transplant dysfunction: value of gadopentetate dimeglumine-enhanced MR imaging. Fernandez MP; Bernardino ME; Neylan JF; Olson RA AJR Am J Roentgenol; 1991 Jun; 156(6):1171-6. PubMed ID: 2028861 [TBL] [Abstract][Full Text] [Related]
13. Improved contrast of enhancing brain lesions on postgadolinium, T1-weighted spin-echo images with use of magnetization transfer. Finelli DA; Hurst GC; Gullapali RP; Bellon EM Radiology; 1994 Feb; 190(2):553-9. PubMed ID: 8284415 [TBL] [Abstract][Full Text] [Related]
14. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging. Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572 [TBL] [Abstract][Full Text] [Related]
15. MR imaging of the brain in patients with AIDS: value of routine use of i.v. gadopentetate dimeglumine. Jensen MC; Brant-Zawadzki M AJR Am J Roentgenol; 1993 Jan; 160(1):153-7. PubMed ID: 8416615 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the safety of standard and triple dose gadodiamide injection in MR imaging of the central nervous system. A double-blind study. Svaland MG; Christensen T; Lundorf E Acta Radiol; 1994 Jul; 35(4):396-9. PubMed ID: 8011392 [TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced MR angiography for the diagnosis of intracranial vascular disease: optimal dose of gadopentetate dimeglumine. Jung HW; Chang KH; Choi DS; Han MH; Han MC AJR Am J Roentgenol; 1995 Nov; 165(5):1251-5. PubMed ID: 7572513 [TBL] [Abstract][Full Text] [Related]
18. Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine. Knopp MV; Runge VM; Essig M; Hartman M; Jansen O; Kirchin MA; Moeller A; Seeberg AH; Lodemann KP Radiology; 2004 Jan; 230(1):55-64. PubMed ID: 14695387 [TBL] [Abstract][Full Text] [Related]
19. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine. Bauner KU; Reiser MF; Huber AM Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911 [TBL] [Abstract][Full Text] [Related]
20. Comparison of cardiovascular changes after administration of gadodiamide injection and gadopentetate dimeglumine in dogs. Bøkenes J; Hustvedt SO; Refsum H Acad Radiol; 1997 Mar; 4(3):204-9. PubMed ID: 9084778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]